Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants
S. Changrob, P. J. Halfmann, H. Liu, J. L. Torres, J. J. C. McGrath, G. Ozorowski, L. Li, M. Kuroda, T. Maemura, M. Huang, D. G. Wilbanks, N.-Y. Zheng, H. L. Turner, S. A. Erickson, Y. Fu, , P. C. Wilson
This paper identifies a broadly neutralizing antibody against SARS-CoV-2 that targets the receptor-binding site and remains effective against multiple Omicron subvariants.
bioRxiv · Oct 31, 2022Immunology